Aptamer-based Proteomic Signature of Intensive Phase Treatment Response in Pulmonary Tuberculosis

BACKGROUND: New drug regimens of greater efficacy and shorter duration are needed for tuberculosis (TB) treatment. The identification of accurate, quantitative, non-culture based markers of treatment response would improve the efficiency of Phase 2 TB drug testing. METHODS: In an unbiased biomarker...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nahid, Payam, Bliven-Sizemore, Erin, Jarlsberg, Leah G., Mary, A, Groote, De, Johnson, John L., Muzanyi, Grace, Engle, Melissa, Weiner, Marc, Janjic, Nebojsa, Sterling, David G., Ochsner, Urs A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4028389/
https://ncbi.nlm.nih.gov/pubmed/24629635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2014.01.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados